Bright pharmaceuticals SE: Accounting for a business combination under IFRS 3

Dominic Detzen*, Sebastian Hoffmann, Henning Zülch

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Bright pharmaceuticals SE: Accounting for a business combination under IFRS 3'. Together they form a unique fingerprint.

Economics, Econometrics and Finance

Social Sciences